跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Deoxysaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Deoxysaph
Approved
STANDARD
Deoxysaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
acd7083c6139fcd0
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
acd7083c6139fcd0
Drug Approval Philippines Name
Deoxysaph
Product Name
Deoxysaph
Registration Number
DRP-13681
Brand Name
Deoxysaph
Generic Name
Ursodeoxycholic Acid
Dosage Form
Film-Coated Tablet
Dosage Strength
300 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Trader
India
Distributor
Ollen Pharma Trading, Inc.
Issuance Date
24 March 2023
Expiry Date
24 March 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
acd7083c6139fcd0
Type
Standard
Back to Philippines FDA Approvals